{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T10:14:19Z","timestamp":1793182459029,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T00:00:00Z","timestamp":1712188800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0210111h0002"],"award-info":[{"award-number":["JP23fk0210111h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0210104s0202"],"award-info":[{"award-number":["JP23fk0210104s0202"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0210123h0001"],"award-info":[{"award-number":["JP23fk0210123h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23fk0210125"],"award-info":[{"award-number":["JP23fk0210125"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23HC2001"],"award-info":[{"award-number":["23HC2001"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23HC2002"],"award-info":[{"award-number":["23HC2002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23HC2003"],"award-info":[{"award-number":["23HC2003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00535-024-02093-z","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T02:01:46Z","timestamp":1712196106000},"page":"494-503","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1007","volume":"59","author":[{"given":"Shun-Ichi","family":"Wakabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuharu","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeji","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namiki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"2093_CR1","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/hepr.13947","volume":"53","author":"H Fujii","year":"2023","unstructured":"Fujii H, Suzuki Y, Sawada K, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2014 to 2018 in Japan: a large-scale multicenter retrospective study. Hepatol Res. 2023;53:1059\u201372.","journal-title":"Hepatol Res"},{"key":"2093_CR2","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/apt.16745","volume":"55","author":"M Higuchi","year":"2022","unstructured":"Higuchi M, Tamaki N, Kurosaki M, et al. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. Aliment Pharmacol Ther. 2022;55:292\u2013301.","journal-title":"Aliment Pharmacol Ther"},{"key":"2093_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1053\/j.gastro.2020.04.048","volume":"159","author":"O Nabi","year":"2020","unstructured":"Nabi O, Lacombe K, Boursier J, et al. Prevalence and risk factors of nonalcoholic fatty liver disease and advanced fibrosis in general population: the French nationwide NASH-CO study. Gastroenterology. 2020;159:791-793.e2.","journal-title":"Gastroenterology"},{"key":"2093_CR4","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/HEP.0000000000000329","volume":"78","author":"O Nabi","year":"2023","unstructured":"Nabi O, Lapidus N, Boursier J, et al. Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study). Hepatology. 2023;78:272\u201383.","journal-title":"Hepatology"},{"key":"2093_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/apt.14401","volume":"47","author":"S Sookoian","year":"2018","unstructured":"Sookoian S, Pirola CJ. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2018;47:16\u201325.","journal-title":"Aliment Pharmacol Ther"},{"key":"2093_CR6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/17474124.2018.1460202","volume":"12","author":"FB Lu","year":"2018","unstructured":"Lu FB, Hu ED, Xu LM, et al. The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12:491\u2013502.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"2093_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/hep4.1519","volume":"4","author":"S Young","year":"2020","unstructured":"Young S, Tariq R, Provenza J, et al. Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis. Hepatol Commun. 2020;4:953\u201372.","journal-title":"Hepatol Commun"},{"key":"2093_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","volume":"15","author":"T Ito","year":"2021","unstructured":"Ito T, Ishigami M, Zou B, et al. The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995\u20132040. Hepatol Int. 2021;15:366\u201379.","journal-title":"Hepatol Int"},{"key":"2093_CR9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:739\u201352.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2093_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/hep.28697","volume":"65","author":"JC Leung","year":"2017","unstructured":"Leung JC, Loong TC, Wei JL, et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology. 2017;65:54\u201364.","journal-title":"Hepatology"},{"key":"2093_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/joim.13069","volume":"288","author":"B Zou","year":"2020","unstructured":"Zou B, Yeo YH, Nguyen VH, et al. Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999\u20132016. J Intern Med. 2020;288:139\u201351.","journal-title":"J Intern Med"},{"key":"2093_CR12","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1002\/hep4.1534","volume":"4","author":"P Golabi","year":"2020","unstructured":"Golabi P, Paik JM, Arshad T, et al. Mortality of NAFLD according to the body composition and presence of metabolic abnormalities. Hepatol Commun. 2020;4:1136\u201348.","journal-title":"Hepatol Commun"},{"key":"2093_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/gutjnl-2020-322564","volume":"71","author":"R Younes","year":"2022","unstructured":"Younes R, Govaere O, Petta S, et al. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach? Gut. 2022;71:382\u201390.","journal-title":"Gut"},{"key":"2093_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep4.1124","volume":"2","author":"H Hagstr\u00f6m","year":"2018","unstructured":"Hagstr\u00f6m H, Nasr P, Ekstedt M, et al. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study. Hepatol Commun. 2018;2:48\u201357.","journal-title":"Hepatol Commun"},{"key":"2093_CR15","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","journal-title":"J Hepatol"},{"key":"2093_CR16","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1016\/j.jhep.2023.12.030","volume":"80","author":"M Nakano","year":"2024","unstructured":"Nakano M, Kawaguchi M, Kawaguchi T. almost identical values of various noninvasive indexes for hepatic fibrosis and steatosis between NAFLD and MASLD in Asia. J Hepatol. 2024;80:e155\u20137.","journal-title":"J Hepatol"},{"key":"2093_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/jgf2.422","volume":"22","author":"K Nagai","year":"2021","unstructured":"Nagai K, Tanaka T, Kodaira N, et al. Data resource profile: JMDC claims database sourced from health insurance societies. J Gen Fam Med. 2021;22:118\u201327.","journal-title":"J Gen Fam Med"},{"key":"2093_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"key":"2093_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/hepr.13790","volume":"52","author":"K Mori","year":"2022","unstructured":"Mori K, Tanaka M, Higashiura Y, et al. High fatty liver index is an independent predictor of ischemic heart disease during a 10-year period in a Japanese population. Hepatol Res. 2022;52:687\u201398.","journal-title":"Hepatol Res"},{"key":"2093_CR20","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler EM, Schouten JN, Hansen BE, et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11:1201\u20134.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2093_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/pds.5213","volume":"30","author":"K Fujihara","year":"2021","unstructured":"Fujihara K, Yamada-Harada M, Matsubayashi Y, et al. Accuracy of Japanese claims data in identifying diabetes-related complications. Pharmacoepidemiol Drug Saf. 2021;30:594\u2013601.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2093_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1097\/MLR.0b013e3181c1328f","volume":"48","author":"MD Spreeuwenberg","year":"2010","unstructured":"Spreeuwenberg MD, Bartak A, Croon MA, et al. The multiple propensity score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental health. Med Care. 2010;48:166\u201374.","journal-title":"Med Care"},{"key":"2093_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","volume":"93","author":"SG Sheth","year":"1998","unstructured":"Sheth SG, Flamm SL, Gordon FD, et al. AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1998;93:44\u20138.","journal-title":"Am J Gastroenterol"},{"key":"2093_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00535-014-0948-9","volume":"50","author":"K Nishioji","year":"2015","unstructured":"Nishioji K, Sumida Y, Kamaguchi M, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011\u20132012. J Gastroenterol. 2015;50:95\u2013108.","journal-title":"J Gastroenterol"},{"key":"2093_CR25","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/hep.23567","volume":"51","author":"K Das","year":"2010","unstructured":"Das K, Das K, Mukherjee PS, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010;51:1593\u2013602.","journal-title":"Hepatology"},{"key":"2093_CR26","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.cgh.2022.06.029","volume":"21","author":"A Tang","year":"2023","unstructured":"Tang A, Ng CH, Phang PH, et al. Comparative burden of metabolic dysfunction in lean NAFLD vs. non-lean NAFLD\u2014a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:1750-1760.e12.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2093_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12876-023-02848-7","volume":"23","author":"S Ishido","year":"2023","unstructured":"Ishido S, Tamaki N, Takahashi Y, et al. Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease. BMC Gastroenterol. 2023;23:211.","journal-title":"BMC Gastroenterol"},{"key":"2093_CR28","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.cgh.2022.11.019","volume":"21","author":"J Ha","year":"2023","unstructured":"Ha J, Yim SY, Karagozian R. Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:2496-2507.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2093_CR29","doi-asserted-by":"publisher","first-page":"620","DOI":"10.14309\/ajg.0000000000000074","volume":"114","author":"Y Chang","year":"2019","unstructured":"Chang Y, Cho YK, Cho J, et al. Alcoholic and nonalcoholic fatty liver disease and liver-related mortality: a cohort study. Am J Gastroenterol. 2019;114:620\u20139.","journal-title":"Am J Gastroenterol"},{"key":"2093_CR30","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1111\/liv.13137","volume":"36","author":"R Karagozian","year":"2016","unstructured":"Karagozian R, Bhardwaj G, Wakefield DB, et al. Obesity paradox in advanced liver disease: obesity is associated with lower mortality in hospitalized patients with cirrhosis. Liver Int. 2016;36:1450\u20136.","journal-title":"Liver Int"},{"key":"2093_CR31","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1111\/liv.14852","volume":"41","author":"D Kim","year":"2021","unstructured":"Kim D, Wijarnpreecha K, Sandhu KK, et al. Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States. Liver Int. 2021;41:1832\u201340.","journal-title":"Liver Int"},{"key":"2093_CR32","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/hepr.13911","volume":"53","author":"M Kawanaka","year":"2023","unstructured":"Kawanaka M, Nishino K, Kawada M, et al. Lean nonalcoholic fatty liver disease: age-dependent differences in pathology, prognosis, and liver-related events. Hepatol Res. 2023;53:829\u201343.","journal-title":"Hepatol Res"},{"key":"2093_CR33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3390\/nu15040891","volume":"15","author":"M Iwaki","year":"2023","unstructured":"Iwaki M, Kobayashi T, Nogami A, et al. Impact of sarcopenia on non-alcoholic fatty liver disease. Nutrients. 2023;15:891.","journal-title":"Nutrients"},{"key":"2093_CR34","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/00365520802588133","volume":"44","author":"K Yasutake","year":"2009","unstructured":"Yasutake K, Nakamuta M, Shima Y, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol. 2009;44:471\u20137.","journal-title":"Scand J Gastroenterol"},{"key":"2093_CR35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/apt.16392","volume":"54","author":"V Ajmera","year":"2021","unstructured":"Ajmera V, Liu A, Bettencourt R, et al. The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography. Aliment Pharmacol Ther. 2021;54:68\u201377.","journal-title":"Aliment Pharmacol Ther"},{"key":"2093_CR36","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1002\/hep.32047","volume":"74","author":"S Vilarinho","year":"2021","unstructured":"Vilarinho S, Ajmera V, Zheng M, et al. Emerging role of genomic analysis in clinical evaluation of lean individuals with NAFLD. Hepatology. 2021;74:2241\u201350.","journal-title":"Hepatology"},{"key":"2093_CR37","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/hep.32774","volume":"77","author":"TC Yip","year":"2023","unstructured":"Yip TC, Vilar-Gomez E, Petta S, et al. Geographical similarity and differences in the burden and genetic predisposition of NAFLD. Hepatology. 2023;77:1404\u201327.","journal-title":"Hepatology"},{"key":"2093_CR38","doi-asserted-by":"publisher","first-page":"e162513","DOI":"10.1172\/JCI162513","volume":"132","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ahlholm N, Luukkonen PK, et al. Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. J Clin Invest. 2022;132:e162513.","journal-title":"J Clin Invest"},{"key":"2093_CR39","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol. 2022;18:55\u201366.","journal-title":"Nat Rev Endocrinol"},{"key":"2093_CR40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/hepr.13764","volume":"52","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Kurosaki M, Huang DQ, et al. Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease. Hepatol Res. 2022;52:497\u2013507.","journal-title":"Hepatol Res"},{"key":"2093_CR41","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/hepr.13950","volume":"53","author":"K Chayama","year":"2023","unstructured":"Chayama K, Hiramatsu A, Shima T, et al. Impact of fibrosis on liver-related event incidence in nonalcoholic fatty liver disease: a multicenter observational study. Hepatol Res. 2023;53:1169\u201384.","journal-title":"Hepatol Res"},{"key":"2093_CR42","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1111\/hepr.13938","volume":"53","author":"K Miura","year":"2023","unstructured":"Miura K, Hayashi H, Kamada Y, et al. Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver disease. Hepatol Res. 2023;53:978\u201388.","journal-title":"Hepatol Res"},{"key":"2093_CR43","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/hepr.13884","volume":"53","author":"H Fujii","year":"2023","unstructured":"Fujii H, Fujii M, Iwaki M, et al. Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease. Hepatol Res. 2023;53:391\u2013400.","journal-title":"Hepatol Res"},{"key":"2093_CR44","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.cgh.2018.12.031","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Yamada G, Vuppalanchi R, et al. Diagnostic accuracy of noninvasive fibrosis models to detect change in fibrosis stage. Clin Gastroenterol Hepatol. 2019;17:1877-1885.e5.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2093_CR45","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jhep.2010.04.033","volume":"53","author":"T Nagaya","year":"2010","unstructured":"Nagaya T, Tanaka N, Suzuki T, et al. Down-regulation of SREBP-1c is associated with the development of burned-out NASH. J Hepatol. 2010;53:724\u201331.","journal-title":"J Hepatol"},{"key":"2093_CR46","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00535-021-01796-x","volume":"56","author":"K Tokushige","year":"2021","unstructured":"Tokushige K, Ikejima K, Ono M, et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis 2020. J Gastroenterol. 2021;56:951\u201363.","journal-title":"J Gastroenterol"},{"key":"2093_CR47","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","volume":"163","author":"MT Long","year":"2022","unstructured":"Long MT, Noureddin M, Lim JK. AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review. Gastroenterology. 2022;163:764-774.e1.","journal-title":"Gastroenterology"},{"key":"2093_CR48","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797\u2013835.","journal-title":"Hepatology"},{"key":"2093_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00535-022-01860-0","volume":"57","author":"J Ampuero","year":"2022","unstructured":"Ampuero J, Gallego-Dur\u00e1n R, Maya-Miles D, et al. Systematic review and meta-analysis: analysis of variables influencing the interpretation of clinical trial results in NAFLD. J Gastroenterol. 2022;57:357\u201371.","journal-title":"J Gastroenterol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-024-02093-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-024-02093-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-024-02093-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T09:02:32Z","timestamp":1716714152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-024-02093-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,4]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2093"],"URL":"https:\/\/doi.org\/10.1007\/s00535-024-02093-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,4]]},"assertion":[{"value":"27 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}